CAT No: 10-101-343 CAS No: 1401708-83-5 Synonyms/Alias: dihexa;1401708-83-5;L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-hexanoic-Tyr-Ile-(6) aminohexanoic amide;9WYX65A5C2;PNB-0408;(2S,3S)-N-(6-amino-6-oxohexyl)-2-[[(2S)-2-(hexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanamide;6-(2-(2-Hexanamido-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)hexanamide;6-[(2S,3S)-2-[(2S)-2-hexanamido-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]hexanamide;Hexanoyl-Tyr-Ile-Ahx-NH2;UNII-9WYX65A5C2;Dihexa (PNB-0408)?;DTXSID701032895;GLXC-25923;ATH-1001;AKOS040759118;CS-6864;DA-62870;HY-16969;PNB-0408
The first line of treatment that will be successful in intreating most cases is the modification of activities, rest and physiotherapy with stretching and eccentric loading exercises
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
As the clinical understanding of these complex illnesses evolves, supporting the body's master antioxidant pathways with highly bioavailable liposomal formulations continues to emerge as a foundational, science-backed management strategy
Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on January 26th, 2026
Uchida, H., Nakajima, Y., Ohtake, K., Ito, J., Morita, M., Kamimura, A., & Kobayashi, J
